Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature.

Visintin A, Knowlton K, Tyminski E, Lin CI, Zheng X, Marquette K, Jain S, Tchistiakova L, Li D, O'Donnell CJ, Maderna A, Cao X, Dunn R, Snyder WB, Abraham AK, Leal M, Shetty S, Barry A, Zawel L, Coyle AJ, Dvorak HF, Jaminet SC.

Mol Cancer Ther. 2015 Aug;14(8):1868-76. doi: 10.1158/1535-7163.MCT-15-0188. Epub 2015 Jun 18.

2.

Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties.

Vendel MC, Favis M, Snyder WB, Huang F, Capili AD, Dong J, Glaser SM, Miller BR, Demarest SJ.

Arch Biochem Biophys. 2012 Oct 15;526(2):188-93. doi: 10.1016/j.abb.2011.12.018. Epub 2012 Jan 2.

PMID:
22230329
3.

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.

Dong J, Sereno A, Aivazian D, Langley E, Miller BR, Snyder WB, Chan E, Cantele M, Morena R, Joseph IB, Boccia A, Virata C, Gamez J, Yco G, Favis M, Wu X, Graff CP, Wang Q, Rohde E, Rennard R, Berquist L, Huang F, Zhang Y, Gao SX, Ho SN, Demarest SJ, Reff ME, Hariharan K, Glaser SM.

MAbs. 2011 May-Jun;3(3):273-88. Epub 2011 May 1.

4.

Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.

Dong J, Sereno A, Snyder WB, Miller BR, Tamraz S, Doern A, Favis M, Wu X, Tran H, Langley E, Joseph I, Boccia A, Kelly R, Wortham K, Wang Q, Berquist L, Huang F, Gao SX, Zhang Y, Lugovskoy A, Martin S, Gouvis H, Berkowitz S, Chiang G, Reff M, Glaser SM, Hariharan K, Demarest SJ.

J Biol Chem. 2011 Feb 11;286(6):4703-17. doi: 10.1074/jbc.M110.184317. Epub 2010 Dec 1.

5.

Stability engineering of scFvs for the development of bispecific and multivalent antibodies.

Miller BR, Demarest SJ, Lugovskoy A, Huang F, Wu X, Snyder WB, Croner LJ, Wang N, Amatucci A, Michaelson JS, Glaser SM.

Protein Eng Des Sel. 2010 Jul;23(7):549-57. doi: 10.1093/protein/gzq028. Epub 2010 May 10.

PMID:
20457695
6.

Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.

Michaelson JS, Demarest SJ, Miller B, Amatucci A, Snyder WB, Wu X, Huang F, Phan S, Gao S, Doern A, Farrington GK, Lugovskoy A, Joseph I, Bailly V, Wang X, Garber E, Browning J, Glaser SM.

MAbs. 2009 Mar-Apr;1(2):128-41. Epub 2009 Mar 11.

7.

Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body.

Babst M, Katzmann DJ, Snyder WB, Wendland B, Emr SD.

Dev Cell. 2002 Aug;3(2):283-9.

9.

Pichia pastoris Pex14p, a phosphorylated peroxisomal membrane protein, is part of a PTS-receptor docking complex and interacts with many peroxins.

Johnson MA, Snyder WB, Cereghino JL, Veenhuis M, Subramani S, Cregg JM.

Yeast. 2001 May;18(7):621-41.

10.

Import of peroxisomal matrix and membrane proteins.

Subramani S, Koller A, Snyder WB.

Annu Rev Biochem. 2000;69:399-418. Review.

PMID:
10966464
11.

The peroxin Pex19p interacts with multiple, integral membrane proteins at the peroxisomal membrane.

Snyder WB, Koller A, Choy AJ, Subramani S.

J Cell Biol. 2000 Jun 12;149(6):1171-8.

12.

Ulnar neuropathy as a complication of macular hole surgery.

Holekamp NM, Meredith TA, Landers MB, Snyder WB, Thompson JT, Berman AJ, Williams S.

Arch Ophthalmol. 1999 Dec;117(12):1607-10. Erratum in: Arch Ophthalmol 2000 Apr;118(4):549.

PMID:
10604664
13.
14.

Pex22p of Pichia pastoris, essential for peroxisomal matrix protein import, anchors the ubiquitin-conjugating enzyme, Pex4p, on the peroxisomal membrane.

Koller A, Snyder WB, Faber KN, Wenzel TJ, Rangell L, Keller GA, Subramani S.

J Cell Biol. 1999 Jul 12;146(1):99-112.

15.

Current popularity of pneumatic retinopexy.

Benson WE, Chan P, Sharma S, Snyder WB, Bloome MA, Birch DG.

Retina. 1999;19(3):238-41.

PMID:
10380030
16.

Pex19p interacts with Pex3p and Pex10p and is essential for peroxisome biogenesis in Pichia pastoris.

Snyder WB, Faber KN, Wenzel TJ, Koller A, Lüers GH, Rangell L, Keller GA, Subramani S.

Mol Biol Cell. 1999 Jun;10(6):1745-61.

17.
18.

Characterization of VPS41, a gene required for vacuolar trafficking and high-affinity iron transport in yeast.

Radisky DC, Snyder WB, Emr SD, Kaplan J.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5662-6.

19.
20.

Visual field defects after macular hole surgery. A new finding.

Hutton WL, Fuller DG, Snyder WB, Fellman RL, Swanson WH.

Ophthalmology. 1996 Dec;103(12):2152-8; discussion 2158-9.

PMID:
9003351
21.
22.
25.
26.

Limiting applications of cryotherapy for severe retinopathy of prematurity.

Spencer R, Hutton WL, Snyder WB, Fuller DG, Fish GE, Vaiser A, Jost BF.

Ophthalmic Surg. 1992 Nov;23(11):766-9.

PMID:
1484670
27.
28.
29.

Contact ultrasonography and hypotonous eyes.

Snyder WB, Lynn JR, Fellman RL, Starita RJ.

Arch Ophthalmol. 1990 Nov;108(11):1516. No abstract available.

PMID:
2244824
30.

Unsuspected renal cell carcinoma metastatic to the choroid nine years after nephrectomy.

Holbach LM, Chévez P, Snyder WB, Font RL.

Am J Ophthalmol. 1990 Oct 15;110(4):441-3. No abstract available.

PMID:
2220990
31.

Vitrectomy in eyes at risk for macular hole formation.

Jost BF, Hutton WL, Fuller DG, Vaiser A, Snyder WB, Fish GE, Spencer R, Birch DG.

Ophthalmology. 1990 Jul;97(7):843-7.

PMID:
2381695
32.

L-shaped accessory sponge exoplant.

Snyder WB, Jost BF, Hutton WL, Vaiser A, Fuller DG, Spencer R.

Am J Ophthalmol. 1989 Aug 15;108(2):203-4. No abstract available.

PMID:
2757108
33.

Temporary keratoprosthesis for combined penetrating keratoplasty, pars plana vitrectomy, and repair of retinal detachment.

Gelender H, Vaiser A, Snyder WB, Fuller DG, Hutton WL.

Ophthalmology. 1988 Jul;95(7):897-901.

PMID:
3050704
34.

An inexpensive fiberoptic light pipe to aid in placement of episcleral radioactive plaques.

Snyder WB, Fuller DG, Fish GE.

Ophthalmic Surg. 1988 Jan;19(1):62-3.

PMID:
3340406
35.
36.

Ultrasonographic features of choroidal malignant melanomas.

Fuller DG, Snyder WB, Hutton WL, Vaiser A.

Arch Ophthalmol. 1979 Aug;97(8):1465-72.

PMID:
464871
37.

Retinal detachment and pseudophakia.

Snyder WB, Bernstein I, Fuller D, Hutton WL, Vaiser A.

Ophthalmology. 1979 Feb;86(2):229-41.

PMID:
530577
38.

Focal parafoveal retinal telangiectasis.

Hutton WL, Snyder WB, Fuller D, Vaiser A.

Arch Ophthalmol. 1978 Aug;96(8):1362-7.

PMID:
678172
39.

Management of surgically dislocated intravitreal lens fragments by pars plana vitrectomy.

Hutton WL, Snyder WB, Vaiser A.

Ophthalmology. 1978 Feb;85(2):176-89.

PMID:
306086
40.

Vitrectomy in the treatment of ocular perforating injuries.

Hutton WL, Snyder WB, Vaiser A.

Am J Ophthalmol. 1976 Jun;81(6):733-9.

PMID:
937426
41.

Pars plana vitrectomy for removal of intravitreous Cysticercus.

Hutton WL, Vaiser A, Snyder WB.

Am J Ophthalmol. 1976 May;81(5):571-3.

PMID:
1275034
42.

Surgical removal of nonmagnetic foreign bodies.

Hutton WL, Snyder WB, Vaiser A.

Am J Ophthalmol. 1975 Nov;80(5):838-43.

PMID:
1190277
43.

Retinal hemorrhage associated with thrombasthenia.

Vaiser A, Hutton WL, Marengo-Rowe AJ, Leveson JE, Snyder WB.

Am J Ophthalmol. 1975 Aug;80(2):258-62.

PMID:
1171626
44.

A coaxial electrode for intraocular diathermy.

Tate GW Jr, Hutton WL, Vaiser A, Snyder WB.

Am J Ophthalmol. 1975 Apr;79(4):691-3.

PMID:
1119526
45.

Laser iridectomy.

Snyder WB, Vaiser A, Hutton WL.

Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975 Mar-Apr;79(2):OP381-6.

PMID:
1170673
46.

Retinal microangiopathy without associated glucose intolerance.

Hutton WL, Snyder WB, Vaiser A, Siperstein MD.

Trans Am Acad Ophthalmol Otolaryngol. 1972 Jul-Aug;76(4):968-80. No abstract available.

PMID:
4666943
48.

Light coagulation for hemorrhagic disciform degeneration of the macula.

Watzke RC, Snyder WB.

Trans Am Acad Ophthalmol Otolaryngol. 1968 May-Jun;72(3):389-95. No abstract available.

PMID:
5659221
49.

Laser coagulation of the retina.

Snyder WB.

Tex Med. 1967 Oct;63(10):48-53. No abstract available.

PMID:
5624297
50.

Fluorescence angiography of ocular tumors.

Snyder WB, Allen L, Frazier O.

Trans Am Acad Ophthalmol Otolaryngol. 1967 Sep-Oct;71(5):820-32. No abstract available.

PMID:
6066200

Supplemental Content

Loading ...
Support Center